26
MSRP:
Now:
€1,362.00 - €3,864.00
Was:
Ponatinib is a multi-targeted tyrosine kinase inhibitor that is active against T315I and other BCR-Abl mutants. It inhibits all tested BCR-Abl mutants in cellular and biochemical assays, suppresses...
26-2712-GEN